Follow
Mary E Ritchey
Mary E Ritchey
CERobs Consulting; Rutgers University
Verified email at medtechepi.com
Title
Cited by
Cited by
Year
Validity of pharmacoepidemiologic drug and diagnosis data
SL West, ME Ritchey, C Poole
Pharmacoepidemiology, 757-794, 2012
2412012
Effect of a pharmacist on adverse drug events and medication errors in outpatients with cardiovascular disease
MD Murray, ME Ritchey, J Wu, W Tu
Archives of internal medicine 169 (8), 757-763, 2009
1602009
Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancer
MD Hackshaw, HE Danysh, J Singh, ME Ritchey, A Ladner, C Taitt, ...
Breast cancer research and treatment 183, 23-39, 2020
692020
Left bundle branch block predicts better survival in women than men receiving cardiac resynchronization therapy: long-term follow-up of∼ 145,000 patients
Z Loring, DA Caños, K Selzman, ND Herz, H Silverman, TE MaCurdy, ...
JACC: Heart Failure 1 (3), 237-244, 2013
592013
Emergency department visits for medical device-associated adverse events among children
C Wang, B Hefflin, JU Cope, TP Gross, MB Ritchie, Y Qi, J Chu
Pediatrics 126 (2), 247-259, 2010
482010
Considerations in characterizing real‐world data relevance and quality for regulatory purposes: a commentary
CJ Girman, ME Ritchey, W Zhou, NA Dreyer
Pharmacoepidemiology and drug safety 28 (4), 439, 2019
332019
Cardiovascular safety during and after use of phentermine and topiramate
ME Ritchey, A Harding, S Hunter, C Peterson, PT Sager, PR Kowey, ...
The Journal of Clinical Endocrinology & Metabolism 104 (2), 513-522, 2019
312019
From clinical phenotype to genotypic modelling: incidence and prevalence of recessive dystrophic epidermolysis bullosa (RDEB)
S Eichstadt, JY Tang, DC Solis, Z Siprashvili, MP Marinkovich, ...
Clinical, cosmetic and investigational dermatology, 933-942, 2019
282019
Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review
MD Hackshaw, HE Danysh, M Henderson, E Wang, N Tu, Z Islam, ...
BMC cancer 21 (1), 967, 2021
242021
Intrauterine device-related uterine perforation incidence and risk (APEX-IUD): a large multisite cohort study
SD Reed, X Zhou, L Ichikawa, JL Gatz, JF Peipert, MA Armstrong, ...
The Lancet 399 (10341), 2103-2112, 2022
192022
Association of the timing of postpartum intrauterine device insertion and breastfeeding with risks of intrauterine device expulsion
MA Armstrong, T Raine-Bennett, SD Reed, J Gatz, D Getahun, ...
JAMA Network Open 5 (2), e2148474-e2148474, 2022
192022
No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer’s disease and related dementia: results from the Drug Repurposing for …
RJ Desai, M Mahesri, SB Lee, VR Varma, T Loeffler, I Schilcher, ...
Brain Communications 4 (5), fcac247, 2022
172022
Identification and validation of uterine perforation, intrauterine device expulsion, and breastfeeding in four health care systems with electronic health records
MS Anthony, MA Armstrong, D Getahun, D Scholes, J Gatz, ...
Clinical epidemiology, 635-643, 2019
142019
Core concepts in pharmacoepidemiology: validation of health outcomes of interest within real‐world healthcare databases
EJ Weinstein, ME Ritchey, V Lo Re III
Pharmacoepidemiology and Drug Safety 32 (1), 1-8, 2023
132023
Falls and fractures in patients with Parkinson’s disease-related psychosis treated with pimavanserin vs atypical antipsychotics: a cohort study
JB Layton, J Forns, ME Turner, C Dempsey, JL Bartsch, MS Anthony, ...
Drugs-real world outcomes, 1-14, 2022
132022
Design of the Association of Uterine Perforation and Expulsion of Intrauterine Device study: a multisite retrospective cohort study
MS Anthony, SD Reed, MA Armstrong, D Getahun, JL Gatz, CW Saltus, ...
American Journal of Obstetrics and Gynecology 224 (6), 599. e1-599. e18, 2021
122021
Engaging stakeholders in pharmacoepidemiology research: Current state and recommendations
W Camelo Castillo, N Heath, J Kim, K Yang, ME Ritchey, S dosReis, ...
Pharmacoepidemiology and Drug Safety 28 (6), 766-776, 2019
122019
A systematic review and meta-analyses on the prevalence of pregnancy outcomes in migraine treated patients: a contribution from the IMI2 ConcePTION project
DC Dudman, F Tauqeer, M Kaur, ME Ritchey, H Li, S Lopez-Leon
Journal of Neurology 269 (2), 742-749, 2022
102022
Real‐world data: Assessing electronic health records and medical claims data to support regulatory decision‐making for drug and biological products
CJ Girman, ME Ritchey, VL Re III
Pharmacoepidemiology and Drug Safety 31 (7), 717, 2022
92022
Increased risk of falls and fractures in patients with psychosis and Parkinson disease
J Forns, JB Layton, J Bartsch, ME Turner, C Dempsey, M Anthony, ...
PLoS one 16 (1), e0246121, 2021
82021
The system can't perform the operation now. Try again later.
Articles 1–20